Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
life sciences
5
×
national blog main
boston blog main
biotech
boston
boston top stories
clinical trials
new york blog main
rna interference
san francisco blog main
alnylam pharmaceuticals
boehringer ingelheim
deals
eli lilly
national top stories
new york top stories
san francisco top stories
sanofi
startups
vc
alexion pharmaceuticals
alirocumab
alnylam
alnylam pharmaceutials
amgen
amy schulman
andreas klein
anna greka
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
barry greene
biontech
car-t
caron jacobson
cigall kadoch
craig mello
curevac
dan ollendorf
dicerna pharmaceuticals
What
medicines
5
×
rna
5
×
new
companies
deal
evidence
interference
long
molecules
pharma
small
abandoning
advance
ago
alnylam
aren’t
baggage
based
bets
bio
biologics
cancer
car
cholesterol
comes
considered
cut
cuts
cutting
data
date
deliver
development
dicerna
diseases
drug
drugs
dtx
edge
effective
Language
unset
Current search:
medicines
×
photo
×
" life sciences "
×
rna
×
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”